Search results
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 1 day agoMuch of Moderna’s focus is on nabbing FDA approval for a respiratory syncytial virus vaccine, a...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 20 hours agoOn the stock market today, Moderna stock surged 12.7% to 125.59. Shares topped a buy point at......
Moderna Inc (MRNA) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with ...
GuruFocus.com via Yahoo Finance· 9 hours agoWe are awaiting FDA approval to proceed with contracts. Q: With regard to moving into the 3 new indications for the INT program. Maybe...second season and ...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 1 day agoA Food and Drug Administration decision on approval of Moderna’s RSV vaccine is expected by May 12,...
Moderna Q1 earnings: lower-than-expected loss of $1.18 billion sets tone for vaccine launch | Invezz
Invezz· 1 day agoModerna Inc (NASDAQ: MRNA) reported a narrower-than-expected loss for the first quarter of the year,...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 1 day agoA...is positive, a CDC advisory committee could also recommend using the vaccine in its meeting in...
Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot.
Barrons.com· 1 day agoModerna reported first-quarter financial results Thursday that soundly beat Wall Street...
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Digital Journal· 1 day agoReports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula ...
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050
FOX 59 Indianapolis· 2 days ago(CSE: BIOV) (OTCQB: BVAXF), Moderna, Inc. (NASDAQ: MRNA), Boundless Bio, Inc. (NASDAQ: BOLD),...
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
Zacks via Yahoo Finance· 3 days agoThe Zacks Consensus Estimate for earnings is pegged at a loss of $3.59 per share. During the first...